Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous vs Single Shot Nerve Block in Extremity Fracture Surgery
NCT02280291Phase 4Completed
- Sponsor
- NYU Langone Health
- Start
- Aug 2013
- Primary completion
- Dec 2018
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 4 trial of ropivacaine hydrochloride liposomal suspension injection in postoperative pain, sponsored by NYU Langone Health. Started Aug 2013; status: completed.
02
Drugs
ropivacaine hydrochloride liposomal suspension injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02280291.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02280291.